Possible impact of inflammatory status on C-telopeptide pyridinoline cross-links of Type i collagen and osteocalcin levels around oral implants with peri-implantitis: A controlled clinical trial

Journal of Oral Rehabilitation

Volumn 35, Issue 12, 2008, Pages 934-939

  Tumer C ^a,c   Aksoy, Y ^b   Guncu G N ^c   Nohutcu, R M ^c   Kilinc, K ^b   Tozum T F ^c  

^a University Faculty of Dentistry   (Turkey)

^b Department of Biochemistry

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Endosseous implants; Inflammation; Osteocalcin; Peri implant sulcus fluid; Pyridinoline cross links

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; OSTEOCALCIN; PEPTIDE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLISM; OSTEOLYSIS; PERIODONTITIS; RADIOGRAPHY; TOOTH IMPLANTATION;

ADULT; BONE RESORPTION; COLLAGEN TYPE I; DENTAL IMPLANTATION, ENDOSSEOUS; FEMALE; HUMANS; MALE; OSTEOCALCIN; PEPTIDES; PERIODONTITIS;

EID: 56349123211     PISSN: 0305182X     EISSN: 13652842     Source Type: Journal    
DOI: 10.1111/j.1365-2842.2008.01879.x     Document Type: Article

References (35)

1. Fiorellini JP, Martuscelli G, Weber HP. Longitudinal studies of implant systems. Periodontol 2000. 1998 17 : 125 131.
2. Esposito M, Grusovin MG, Coulthard P, Worthington HV. Interventions for replacing missing teeth: treatment of perimplantitis. Cochrane Database Syst Rev. 2006 3 : CD004970.
3. Van der Weijden GA, van Bemmel KM, Renvert S. Implant therapy in partially edentulous, periodontally compromised patients: a review. J Clin Periodontol. 2005 32 : 506 511.
4. Buser D, Mericske-Stern R, Bernard JP, Behneke A, Behneke N, Hirt HP et al. Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective multi-center study with 2359 implants. Clin Oral Implants Res. 1997 8 : 161 172.
5. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res. 2002 13 : 637 643.
6. Friedmann A, Friedrichs M, Kaner D, Kleber BM, Bernimoulin JP. Calprotectin and cross-linked N-terminal telopeptides in peri-implant and gingival crevicular fluid. Clin Oral Implants Res. 2006 17 : 527 532.
7. Moheng P, Feryn JM. Clinical and biologic factors related to oral implant failure: a 2-year follow-up study. Implant Dent. 2005 14 : 281 288.
8. Oringer RJ, Palys MD, Iranmanesh A, Fiorellini JP, Haffajee AD, Socransky SS et al. C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res. 1998 9 : 365 373.
9. Reinhardt RA, Sanderfer VJ, Meinberg TA, Nummikoski P, Lee HM, Marx DB. Local biochemical markers of bone turnover: relationship to subsequent density of healing alveolar bone defects. J Clin Periodontol. 2004 31 : 223 228.
10. Klinge B, Hultin M, Berglundh T. Peri-implantitis. Dent Clin North Am. 2005 49 : 661 676.
11. Salvi GE, Lang NP. Diagnostic parameters for monitoring peri-implant conditions. Int J Oral Maxillofac Implants. 2004 19 (Suppl 116 127.
12. Tözüm TF, Turkyilmaz I, Yamalik N, Tümer C, Kilinc A, Kilinc K et al. Analysis of the possible impact of inflammation severity and early and delayed loading on nitric oxide metabolism around oral implants. Int J Oral Maxillofac Implants. 2005 20 : 547 556.
13. Tözüm TF, Turkyilmaz I, Yamalik N, Tümer C, Kilinc A, Kilinc K et al. The effect of delayed versus early loading on nitric oxide metabolism around oral implants: an 18-month comparative follow-up study. Int J Oral Maxillofac Implants. 2007 22 : 53 62.
14. Lindhe J, Berglundh T, Ericsson I, Liljenberg B, Marinello C. Experimental breakdown of peri-implant and periodontal tissues. A study in the beagle dog. Clin Oral Implants Res. 1992 3 : 9 16.
15. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993 39 : 635 640.
16. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res. 1993 8 : 127 132.
17. Giannobile WV. Crevicular fluid biomarkers of oral bone loss. Curr Opin Periodontol. 1997 4 : 11 20.
18. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol. 1995 22 : 903 910.
19. Palys MD, Haffajee AD, Socransky SS, Giannobile WV. Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J Clin Periodontol. 1998 25 : 865 871.
20. Lian JB, Gundberg CM Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res. 1988 226 : 267 291.
21. Lee AJ, Walsh TF, Hodges SJ, Rawlinson A. Gingival crevicular fluid osteocalcin in adult periodontitis. J Clin Periodontol. 1999 26 : 252 256.
22. Nakashima K, Giannopoulou C, Andersen E, Roehrich N, Brochut P, Dubrez B et al. A longitudinal study of various crevicular fluid components as markers of periodontal disease activity. J Clin Periodontol. 1996 23 : 832 838.
23. Nakashima K, Roehrich N, Cimasoni G. Osteocalcin, prostaglandin E2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol. 1994 21 : 327 333.
24. McCauley LK, Nohutcu RM. Mediators of periodontal osseous destruction and remodeling: principles and implications for diagnosis and therapy. J Periodontol. 2002 73 : 1377 1391.
25. Gargiulo AW, Wentz FM, Orban B. Dimensions and relations of dentogingival junction in humans. J Periodontol. 1961 32 : 261 267.
26. Sillness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964 22 : 121 135.
27. Löe H, Sillness J. Periodontal disease in pregnancy. I. Prevalance and severity. Acta Odontol Scand. 1963 21 : 533 551.
28. Nowicki D, Vogel RI, Melcer S, Deasy MJ. The gingival bleeding time index. J Periodontol. 1981 52 : 260 262.
29. Renvert S, Roos-Jansåker AM, Lindahl C, Renvert H, Rutger Persson G. Infection at titanium implants with or without a clinical diagnosis of inflammation. Clin Oral Implants Res. 2007 8 : 509 516.
30. Deinzer R, Mossanen BS, Herforth A. Methodological considerations in the assessment of gingival crevicular fluid volume. J Clin Periodontol. 2000 27 : 481 488.
31. Talonpoika JT, Hamalainen MM. Type I collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol. 1994 21 : 320 326.
32. Windhagen H, Witte F, Hurschler C, Maciejewski O, Linnenberg D, Thorey F. Bone turnover during distraction osteogenesis in an experimental sheep model. Arch Orthop Trauma Surg. 2002 122 : 279 282.
33. Haffajee AD, Socransky SS, Lindhe J, Kent RL, Okamoto H, Yoneyama T. Clinical risk indicators for periodontal attachment loss. J Clin Periodontol. 1991 18 : 117 125.
34. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci. 2007 1098 : 230 251.
35. Shibutani T, Murahashi Y, Tsukada E, Iwayama Y, Heersche JN. Experimentally induced periodontitis in beagle dogs causes rapid increases in osteoclastic resorption of alveolar bone. J Periodontol. 1997 68 : 385 391.